{
  "url": "https://openlegislation.uk/human-medicines-regulations-2012/regulation-65B",
  "json_url": "https://openlegislation.uk/human-medicines-regulations-2012/regulation-65B.json",
  "legislation": "uksi/2012/1916",
  "legislation_title": "The Human Medicines Regulations 2012",
  "legislation_url": "https://openlegislation.uk/human-medicines-regulations-2012",
  "path": "regulation/65B",
  "kind": "regulation",
  "number": "65B",
  "heading": "Validity of conditional marketing authorisation",
  "text": "(1) A conditional marketing authorisation remains in force—\n(a) for an initial period of one year beginning with the date on which it is granted; and\n(b) if it is renewed in accordance with regulation 66B, for further periods of one year beginning with the date on which the renewal is granted.\n(2) If an application for the renewal or further renewal of a conditional marketing authorisation is made in accordance with regulation 66B the authorisation remains in force until the licensing authority notifies the applicant of its decision on the application.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "F",
      "label": "F1",
      "text": "Regs. 65B, 65C inserted (31.12.2020) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), regs. 1, 72 (as amended by S.I. 2020/1488, reg. 1, Sch. 2 para. 54); 2020 c. 1, Sch. 5 para. 1(1)"
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2012/1916/regulation/65B",
    "retrieved_at": "2026-10-29T01:24:34.993203+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}